Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06047080 |
|---|---|
| Brief Title: | An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma |
| First Submitted : | September 14, 2023 |
| First Submitted that Met QC Criteria : | September 14, 2023 |
| First Posted : | September 21, 2023 |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 8, 2024 |